Skip to main content
Premium Trial:

Request an Annual Quote

Spotfire Fourth Quarter Sales Exceed $1 Million

Premium

CAMBRIDGE, Mass.-- Spotfire, a bioinformatics software provider, reported that its fourth quarter earnings in 1998 exceeded $1 million and that the company gained 11 new customers during the quarter, including Ariad Pharmaceuticals, Bristol-Myers Squibb, and Rohm and Haas.

Spotfire said sales of its suite of research and development discovery software have jumped dramatically during the past six months, and that its 134 customers include 19 of the top 22 pharmaceutical companies. The company reported that sales were spurred by the addition to its product line of Spotfire Discovery Server, which includes flagship product Spotfire Pro as well as Structure Visualizer and Decision Explorer.

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.